72P - Cemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)
| Autor: | Moreno, V., Gil-Martin, M., Johnson, M.L., Aljumaily, R., Lopez Criado, P., Northfelt, D.W., Crittenden, M., Jabbour, S., Rosen, L., Garrido, P., Hervás Morón, A., Rietschel, P., Mohan, K.K., Li, J., Stankevich, E., Feng, M., Lowy, I., Fury, M.G. |
|---|---|
| Zdroj: | In Annals of Oncology December 2018 29 Supplement 10:x26-x26 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|